Clinical Trial Update: Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study [Phase 2]

View source ↗

Summary

Phase II single-arm study evaluating pemetrexed plus erlotinib as salvage therapy in metastatic biliary tract cancer after failure of gemcitabine-containing che…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Samsung Medical Center | Conditions: Biliary Tract Cancer | Phase 2 | Status: UNKNOWN